7-2538613-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_152743.4(BRAT1):​c.1922C>G​(p.Ala641Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A641V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.000024 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

BRAT1
NM_152743.4 missense

Scores

3
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.350

Publications

4 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04603821).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.1922C>G p.Ala641Gly missense_variant Exon 14 of 14 ENST00000340611.9 NP_689956.2 Q6PJG6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.1922C>G p.Ala641Gly missense_variant Exon 14 of 14 1 NM_152743.4 ENSP00000339637.4 Q6PJG6-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.000195
AC:
43
AN:
220304
AF XY:
0.000236
show subpopulations
Gnomad AFR exome
AF:
0.000224
Gnomad AMR exome
AF:
0.000330
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000581
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000280
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000236
AC:
34
AN:
1442738
Hom.:
0
Cov.:
70
AF XY:
0.0000237
AC XY:
17
AN XY:
718032
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33372
American (AMR)
AF:
0.000410
AC:
18
AN:
43926
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25968
East Asian (EAS)
AF:
0.000127
AC:
5
AN:
39368
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85858
European-Finnish (FIN)
AF:
0.0000259
AC:
1
AN:
38602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
0.00000901
AC:
10
AN:
1109876
Other (OTH)
AF:
0.00
AC:
0
AN:
60028
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.256
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
ExAC
AF:
0.000462
AC:
55

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
0.28
DANN
Benign
0.66
DEOGEN2
Benign
0.066
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.53
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.046
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
1.5
L
PhyloP100
-0.35
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.5
N
REVEL
Benign
0.23
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.095
T
Polyphen
0.31
B
Vest4
0.16
MutPred
0.48
Loss of helix (P = 0.0196);
MVP
0.048
MPC
0.069
ClinPred
0.058
T
GERP RS
-11
Varity_R
0.090
gMVP
0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113030000; hg19: chr7-2578247; API